ClinicalTrials.gov
ClinicalTrials.gov Menu

Concurrent Ipilimumab and Stereotactic Ablative Radiation Therapy (SART) for Oligometastatic But Unresectable Melanoma (SART)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01565837
Recruitment Status : Unknown
Verified January 2016 by Wolfram Samlowski, Comprehensive Cancer Centers of Nevada.
Recruitment status was:  Recruiting
First Posted : March 29, 2012
Last Update Posted : February 1, 2016
Sponsor:
Collaborator:
Comprehensive Cancer Centers of Nevada
Information provided by (Responsible Party):
Wolfram Samlowski, Comprehensive Cancer Centers of Nevada

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : November 2016
  Estimated Study Completion Date : November 2017